AQEMIA

AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AI and atomic scale physics, to design novel drugs tailored for specific therapeutic targets.

Domain

aqemia.com

Country

France

Employees

101-250

Last Funding

$7.4M

Founded

2019

Frequently Asked Questions

What technologies does AQEMIA use?+

AQEMIA uses 9 technologies including Google Analytics, Google Tag Manager, Next.js.

What industry is AQEMIA in?+

AQEMIA operates in the Artificial Intelligence (AI) industry.

Where is AQEMIA based?+

AQEMIA is headquartered in France.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026